Skip to main content
. 2018 Jul 21;10(3):101. doi: 10.3390/pharmaceutics10030101

Table 1.

Details of the systems used here for MD simulations. Molecular content and average volumes for API–polymer blends, and pure systems.

Polymer Npol a Nmon b API Napi c m d w(API) e V f
EEC 14 40 FLA 95 108,631 24.6 161.0
PAA 28 40 FLA 95 107,486 24.9 133.8
PSA 12 40 FLA 95 99,774 23.2 139.2
PVP 18 40 FLA 95 106,778 25.0 152.0
EEC 14 40 FLA 190 135,348 39.5 193.5
PAA 28 40 FLA 190 134,203 39.8 166.5
PSA 12 40 FLA 190 126,491 37.7 171.4
PVP 18 40 FLA 190 133,495 40.0 184.1
EEC 14 40 PAC 149 108,617 24.6 167.5
PAA 28 40 PAC 149 107,472 24.8 140.2
PSA 12 40 PAC 149 99,761 23.2 144.9
PVP 18 40 PAC 149 106,764 25.0 157.0
EEC 14 40 PAC 298 135,321 39.5 206.3
PAA 28 40 PAC 298 134,176 39.8 179.5
PSA 12 40 PAC 298 126,464 37.6 183.6
PVP 18 40 PAC 298 133,468 40.0 195.7
EEC 14 40 81,913 0 128.7
PAA 28 40 80,769 0 100.2
PSA 12 40 88,446 0 107.3
PVP 18 40 80,061 0 120.1
FLA 302 84,933 100.0 104.9
PAC 475 85,130 100.0 128.0

a Number of polymer chains; b Number of monomers per polymer chain; c Number of API molecules; d Total mass of the system in atomic mass units; e API concentration in weight percent; f Average volume in MD simulations in nm3.